|
US2013059746A1
|
|
Gene expression profiling of cytogenetic abnormalities
|
|
US2013209446A1
|
|
Copy Number Variant-Dependent Genes As Diagnostic Tools, Predictive Biomarkers And Therapeutic Targets
|
|
US2012269802A1
|
|
Treatment And Prognosis With Thalidomide In Multiple Myeloma Based on Karyotyping And Gene Expression Profiling
|
|
US2010316629A1
|
|
Use of gene expression profiling to predict survival in cancer patient
|
|
US2010144673A1
|
|
Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling
|
|
US2010152136A1
|
|
TP53 Gene expression and uses thereof
|
|
US2008267950A1
|
|
Methods of controlling bone loss by inhibiting DKK1
|
